Inflammatory monocytes and macrophages are innate im-mune cells that promote the growth and complication of atherosclerotic lesions. Once recruited to the arterial wall, mononuclear phagocytes can ingest lipoproteins. Often, the cells produce proinflammatory mediators and differentiate into foam cells. Activated macrophages also elaborate prote-ases that weaken the plaque’s extracellular matrix.1,2 In early-stage atherosclerosis in mice, most plaque macrophages are direct progeny of recruited blood monocytes that originate in the bone marrow and spleen. In advanced disease, monocyte-derived macrophages proliferate locally, a process that con-tributes dominantly to the cell population in mature plaques.3 Hence, in early and in late disease s...
Atherosclerosis is a multifactorial chronic inflammatory disease and is largely responsible for card...
There are many macrophages in the atherosclerotic lesion. Mononuclear cells begin to migrate into th...
Atherosclerosis initiation and progression is controlled by inflammatory molecular and cellular medi...
Atherosclerosis is one of the leading causes of death and disability worldwide. It is a complex dise...
During the inflammatory response that drives atherogenesis, macrophages accumulate progressively in ...
In atherosclerosis, the accumulation of apolipoprotein B-lipoproteins in the matrix beneath the endo...
Cardiovascular disease, a leading cause of mortality in developed countries, is mainly caused by ath...
Atherosclerosis is the main pathological basis of most cardiovascular diseases and the leading healt...
Macrophages represent a cell type that has been widely described in the context of atherosclerosis s...
Atherosclerosis is a chronic inflammatory disease occurring within the artery wall and is an underly...
Atherosclerosis is the pathological process that underlies the development of cardiovascular disease...
Macrophages are key players in atherosclerotic lesions, regulating the local inflammatory milieu and...
Atherosclerosis can be regarded as chronic inflammatory disease driven by lipid accumulation in the ...
Macrophages are highly heterogeneous and plastic cells. They were shown to play a critical role in a...
Macrophages are key players in atherosclerotic lesions, regulating the local inflammatory milieu and...
Atherosclerosis is a multifactorial chronic inflammatory disease and is largely responsible for card...
There are many macrophages in the atherosclerotic lesion. Mononuclear cells begin to migrate into th...
Atherosclerosis initiation and progression is controlled by inflammatory molecular and cellular medi...
Atherosclerosis is one of the leading causes of death and disability worldwide. It is a complex dise...
During the inflammatory response that drives atherogenesis, macrophages accumulate progressively in ...
In atherosclerosis, the accumulation of apolipoprotein B-lipoproteins in the matrix beneath the endo...
Cardiovascular disease, a leading cause of mortality in developed countries, is mainly caused by ath...
Atherosclerosis is the main pathological basis of most cardiovascular diseases and the leading healt...
Macrophages represent a cell type that has been widely described in the context of atherosclerosis s...
Atherosclerosis is a chronic inflammatory disease occurring within the artery wall and is an underly...
Atherosclerosis is the pathological process that underlies the development of cardiovascular disease...
Macrophages are key players in atherosclerotic lesions, regulating the local inflammatory milieu and...
Atherosclerosis can be regarded as chronic inflammatory disease driven by lipid accumulation in the ...
Macrophages are highly heterogeneous and plastic cells. They were shown to play a critical role in a...
Macrophages are key players in atherosclerotic lesions, regulating the local inflammatory milieu and...
Atherosclerosis is a multifactorial chronic inflammatory disease and is largely responsible for card...
There are many macrophages in the atherosclerotic lesion. Mononuclear cells begin to migrate into th...
Atherosclerosis initiation and progression is controlled by inflammatory molecular and cellular medi...